Jan Lichtenberg
Papers
1
Total Citations
124
H-Index
1
About
Jan Lichtenberg is a leading figure in the development of advanced 3D cell culture technologies, with a primary focus on creating physiologically relevant in vitro models for drug discovery and toxicology. His most impactful work centers on the engineering of scaffold-free spherical tumor microtissues, a breakthrough that bridges the critical gap between academic research and industrial high-throughput screening. His seminal 2011 paper on automated production and drug sensitivity testing of these microtissues, which has garnered over 124 citations, laid the groundwork for scalable, reproducible 3D assays. Lichtenberg’s major contribution lies in translating complex tissue biology into robust, automated platforms that better mimic in vivo tumor microenvironments than traditional 2D cultures. This innovation directly addresses a key bottleneck in preclinical drug development, enabling more accurate prediction of therapeutic efficacy and toxicity. Through his work, Lichtenberg has helped drive the industrial adoption of 3D models, significantly impacting how pharmaceutical companies evaluate drug candidates and moving the field closer to reducing reliance on animal testing.
Research Focus
Key Achievements
Top Papers
- 1